[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100520668":3},{"organization":4,"outcomesModule":7,"designInfo":19,"detailedDescription":18,"studyPopulation":18,"armGroups":25,"interventions":36,"overallOfficials":42,"centralContacts":46,"locations":51,"responsibleParty":68,"collaborators":18,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":18,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":18,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":54,"whyStopped":18,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"First Hospital of China Medical University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":18},[9],{"measure":10,"description":11,"timeFrame":12},"Survival index","DFS\u002FOS","3 years",[14],{"measure":15,"description":16,"timeFrame":17},"Quality of life index","Perioperative survival index of patients with multiple cancer types","3years",null,{"allocation":20,"interventionModel":21,"interventionModelDescription":18,"primaryPurpose":22,"observationalModel":18,"timePerspective":18,"maskingInfo":23},"RANDOMIZED","SEQUENTIAL","TREATMENT",{"masking":24,"maskingDescription":18,"whoMasked":18},"NONE",[26,32],{"label":27,"type":28,"description":29,"interventionNames":30},"interventian group","EXPERIMENTAL","Intensive nutritional interventions based on real-world treatments",[31],"Dietary Supplement: Nutritional therapy",{"label":33,"type":28,"description":34,"interventionNames":35},"control group","Nutritional guidance and education based on real world treatments",[31],[37],{"type":38,"name":39,"description":40,"armGroupLabels":41,"otherNames":18},"DIETARY_SUPPLEMENT","Nutritional therapy","Intensive nutritional therapy based on real world therapy",[33,27],[43],{"name":44,"affiliation":5,"role":45},"Kai Li, MD","STUDY_DIRECTOR",[47],{"name":44,"role":48,"phone":49,"phoneExt":18,"email":50},"CONTACT","8613998245233","cmu1h_likai@163.com",[52],{"facility":53,"status":54,"city":55,"state":56,"zip":18,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"The First Affiliated Hospital of China Medical University","RECRUITING","Shenyang","Liaoning","China","CN",{"type":60,"coordinates":61},"Point",[62,63],123.43278,41.79222,{"lat":63,"lon":62},[66],{"name":44,"role":48,"phone":67,"phoneExt":18,"email":50},"+8613998245233",{"type":69,"investigatorFullName":70,"investigatorTitle":71,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Kai Li","Deputy Director of surgical Oncology","100520668","nutritional-intervention-for-patients-with-multiple-cancer-types-100520668",false,"NCT06059560","Nutritional Intervention for Patients With Multiple Cancer Types","An Open, Real-world Study of the Effects of Perioperative Intensive Nutritional Management on Short-term Quality of Life and Long-term Life Outcomes in Patients With Multiple Cancers","Inclusion Criteria:\n\n* ① Age ≥18 years old, \\\u003C80 years old, male or female; ② The patient signed the informed consent and volunteered to participate in the study; ③ Patients with malignant tumors (laryngeal cancer, esophageal cancer, lung cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer) evaluated by clinical stage II to IV; ④ Patients undergoing tumor surgery; ⑤ Patients with NRS 2002 score ≥ 3 after management risk screening; ⑥ Basic reading and communication skills; ⑦ Have the ability to act; Patients with a life expectancy greater than 6 months;\n\nExclusion Criteria:\n\n* ① Acute onset of chronic disease; ② Pregnant or lactating women; ③ Patients with contraindications and no tumor surgery; (4) Patients with malignant tumors (laryngeal cancer, esophageal cancer, lung cancer, stomach cancer, colorectal cancer, liver cancer, pancreatic cancer) were confirmed by pathology and\u002For cytology after surgery; ⑤ Combined with cognitive dysfunction, mental disorder, consciousness disorder or unwillingness to cooperate; ⑥ Patients with severe gastrointestinal symptoms, liver and renal insufficiency (alanine aminotransferase ALT≥2 times the upper limit of normal value; Total bilirubin Tbil≥2 times the upper limit of normal value; Creatinine Cr≥2 times the upper limit of normal value); (7) Patients with two or more types of tumors; Long-term bed rest, hemiplegia or coma; ⑨ Severe dysfunction of liver, kidney and other organs; ⑩ Allergy or intolerance to nutrients or their main components (such as lactose or galactose, etc.).","ALL","18 Years","80 Years",{"count":83,"type":84},1000,"ESTIMATED","INTERVENTIONAL",[87],"NA","To evaluate the nutritional status of patients with different types of tumors by continuous nutritional intervention and follow-up intervention in the perioperative period,and the impact on progression-free survival\u002Fsurvival and quality of life.",[90],"Cancer",[92,93],"nutrition","prognosis","2023-09-22",{"date":96,"type":97},"2023-09-28","ACTUAL",{"date":99,"type":84},"2023-10-01",{"date":101,"type":84},"2026-10-01",{"name":5,"class":6},1]